https://www.igm.cnr.it/laminopatie/wp-content/uploads/2020/09/icona-pub.png150150lampresshttps://www.igm.cnr.it/laminopatie/wp-content/uploads/2023/08/Top_Lamino_2023.pnglampress2021-09-23 14:33:262022-01-03 09:57:15Inhibition of the NLRP3 inflammasome improves lifespan in animal murine model of Hutchinson-Gilford Progeria.
https://www.igm.cnr.it/laminopatie/wp-content/uploads/2020/09/icona-pub.png150150lampresshttps://www.igm.cnr.it/laminopatie/wp-content/uploads/2023/08/Top_Lamino_2023.pnglampress2021-09-23 14:13:072022-01-03 09:58:38Genetic reduction of mTOR extends lifespan in a mouse model of Hutchinson-Gilford Progeria syndrome
https://www.igm.cnr.it/laminopatie/wp-content/uploads/2020/09/icona-pub.png150150lampresshttps://www.igm.cnr.it/laminopatie/wp-content/uploads/2023/08/Top_Lamino_2023.pnglampress2021-09-22 09:23:392021-09-22 09:25:54Lonafarnib: First Approval
https://www.igm.cnr.it/laminopatie/wp-content/uploads/2020/09/icona-pub.png150150lampresshttps://www.igm.cnr.it/laminopatie/wp-content/uploads/2023/08/Top_Lamino_2023.pnglampress2021-06-23 08:08:272021-09-01 08:20:28Cytokine Profile in Striated Muscle Laminopathies: New Promising Biomarkers for Disease Prediction
https://www.igm.cnr.it/laminopatie/wp-content/uploads/2020/09/icona-pub.png150150lampresshttps://www.igm.cnr.it/laminopatie/wp-content/uploads/2023/08/Top_Lamino_2023.pnglampress2021-04-19 08:16:442021-09-01 08:20:11Case Report: An Atypical Form of Familial Partial Lipodystrophy Type 2 Due to Mutation in the Rod Domain of Lamin A/C
https://www.igm.cnr.it/laminopatie/wp-content/uploads/2020/09/icona-pub.png150150lampresshttps://www.igm.cnr.it/laminopatie/wp-content/uploads/2023/08/Top_Lamino_2023.pnglampress2021-04-11 08:22:022021-09-01 08:20:03International retrospective natural history study of LMNA-related congenital muscular dystrophy
https://www.igm.cnr.it/laminopatie/wp-content/uploads/2020/09/icona-pub.png150150lampresshttps://www.igm.cnr.it/laminopatie/wp-content/uploads/2023/08/Top_Lamino_2023.pnglampress2021-04-10 08:13:322021-09-01 08:56:18FDA News Releas FDA Approves First Treatment for Hutchinson-Gilford Progeria Syndrome and Some Progeroid Laminopathies
